Thomson Medical granted 3 months extension to restore public float
SGX previously rejected the company’s appeal for an extension.
SGX granted Thomson Medical an additional three months until 10 April 2024, to restore its public float under Rule 723 of the SGX-ST Listing Manual.
The grant comes after the company's appeal on 12 January.
The company also appealed for an extension on 2 January, but SGX rejected the proposed extension.
Thomson Medical’s public shares dipped to 9.98% in September 2023.
SGX gave the healthcare provider an initial three months and an extension of one month to restore their public float.
The company had applied for a grace period to restore its public float thrice.